StrataGRT: Package Insert and Label Information

Marnel Pharmaceuticals, Inc.

Rx Only

For topical use only

Federal Law restricts this device to sale by or on the order of a licensed healthcare practitioner.

[EN] Description

StrataGRT is an occlusive, non-resorbable, self-drying and transparent gel.

When used as directed, StrataGRT dries to form a protective layer that is gas permeable and waterproof which hydrates and protects chronic and hard to treat wounds.

StrataGRT helps to promote a moist healing environment. This moist wound healing environment promotes faster re-epithelialization* and reduces the skin’s acute inflammatory response.

StrataGRT is suitable for exposed areas like the face and neck as well as joints and hairy areas without the need for shaving.

Indication for use

StrataGRT is intended to be used under the direction of healthcare practitioners in the management of chronic and hard to treat wounds.

StrataGRT is indicated for use on all types of chronic and acute wounds.

StrataGRT may be directly applied to fresh incisions and excisions, open wounds and compromised skin surfaces.

StrataGRT gel is bacteriostatic and inert.

StrataGRT contains no alcohols, parabens or fragrances.

StrataGRT can be used with or without a secondary protective dressing.

StrataGRT is suitable for infants, children, people with sensitive skin, during pregnancy and while breastfeeding.

StrataGRT is intended for single patient use.

Directions for use

On first use of 0.7 oz (20 g) tubes remove the cap, cut the nozzle tip of the tube and close with the cap after use.

Ensure that the affected superficial area is cleaned before each application.

Gently pat dry as much excess exudate or wound fluid from the area as possible prior to gel application.

For best results StrataGRT should be maintained in continuous contact with the skin (24 hours a day/7 days aweek).

On wounds not requiring a secondary dressing:

Apply a thin layer of StrataGRT to the affected area and allow the gel to dry.

When applied correctly to exposed areas, StrataGRT should be dry in 5-6 minutes.

If it takes longer to dry you have probably applied too much.

Gently remove the excess with a clean tissue or gauze and allow the drying process to continue.

StrataGRT should be applied twice daily to exposed areas or as advised by your physician.

If StrataGRT has been removed by washing, it should be reapplied.

On wounds requiring a secondary dressing:

Apply a thin layer of StrataGRT then cover with secondary dressing.

Drying is not necessary.

StrataGRT should be reapplied when changing the dressing or checking the wound progress, or as advised by your physician.

How much StrataGRT do I need?

StrataGRT gel is an advanced formulation that requires substantially less product per application than creams or gels.

StrataGRT 0.7 oz (20g) is enough to treat an area of 5X5 inch (12X12 cm) twice per day for 30 days.


  • For external use only.
  • StrataGRT should not be placed in contact with the eyes.
  • StrataGRT should not be applied over other skin treatment without the advice of your physician.
  • StrataGRT may stain clothing if not completely dry. If staining occurs, dry cleaning should be able to remove it without damaging the fabric.
  • For correct storage please reclose the tube tightly with the cap.
  • If irritation occurs, discontinue use and consult your physician.
  • Keep out of the reach of children.
  • Do not use after the expiration (EXP) date printed on the tube. The expiration (EXP) date does not change once the tube has been opened.
  • Do not use if the tube is damaged.


Do not administer to patients with known hypersensitivity to the ingredients of this product.


Ingredients: Linear dimethylpolysiloxanes, octamethyltrisiloxane and siloxane resin.

How supplied:

StrataGRT 0.7 oz (20g) tube

Product Identification code:


image description
(click image for full-size original)
image description
(click image for full-size original)

Product Information
Product Type Item Code (Source) NHRIC:73661-422
Inactive Ingredients
Ingredient Name Strength
# Item Code Package Description Multilevel Packaging
1 NHRIC:73661-422-20 1 TUBE in 1 BOX contains a TUBE
1 20 g in 1 TUBE This package is contained within the BOX (73661-422-20)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
exempt device NAD 07/07/2020
Labeler — Marnel Pharmaceuticals, Inc. (080161449)
Name Address ID/FEI Operations
Stratpharma AG 483232695 manufacture

Revised: 07/2020 Marnel Pharmaceuticals, Inc. provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2021. All Rights Reserved.